Skip to main content
Premium Trial:

Request an Annual Quote

Oxford Molecular Buys Software Tool Developer

Premium

OXFORD, UK--Oxford Molecular Group here acquired international software tool developer Chemical Design and its Chem-X software to increase Oxford's product offerings in chemoinformatics, molecular design, and combinatorial chemistry. Chem-X used by some companies in combination with Oxford's RS3 Discovery product, is licensed to over 700 users worldwide on Windows NT and Unix platforms. Oxford Molecular also said it plans to tailor Chem-X and RS3 Discovery to provide more flexible systems and to leverage the combination of technologies. The acquisition will extend the company's capabilities in the areas of library registration, robotics integration, and library design.

Filed under

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.